Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy

被引：8
作者：
Liu, Lixin [1 ]
Chen, Yiman [1 ]
Li, Xuan [2 ]
Wang, Juan [3 ]
Yang, Lina [1 ,4 ]
机构：
[1] China Med Univ, Hosp 1, Dept Geriatr, 155th Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Hosp 1, Dept Vasc & Thyroid Surg, Shenyang 110001, Liaoning, Peoples R China
[3] China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Liaoning, Peoples R China
[4] China Med Univ, Hosp 1, Dept Int Phys Examinat Ctr, Shenyang 110001, Liaoning, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2024年 / 175卷
基金：
中国国家自然科学基金;
关键词：
Diabetic Nephropathy; Mesenchymal stem cells; Exosome; Treatment; KIDNEY-DISEASE; IN-VITRO; MATURATION; RECEPTOR; STAGE;
D O I：
10.1016/j.biopha.2024.116672
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetic patients, with its incidence continuously increasing in recent years. DN causes renal tissue damage and functional decline, expedites the aging process of the kidneys, and may ultimately progress leading to end-stage renal disease, severely impacting the patient's quality of life and prognosis. Mesenchymal stem cells (MSCs) are highly valued for their multipotent differentiation, paracrine functions, immunomodulatory effects, and capacity for tissue repair. Particularly, exosomes (Exo) derived from MSCs (MSCs-Exo) are rich in bioactive molecules and facilitate intercellular communication, participating in various physiological and pathological processes. MSCs and MSCsExo, in particular, have been demonstrated to have therapeutic effects in DN treatment research by encouraging tissue repair, fibrosis inhibition, and inflammation reduction. Research has shown that MSCs and MSCs-Exo have therapeutic effects in DN treatment by promoting tissue repair, inhibiting fibrosis, and reducing inflammation. Recent studies underscore the potential of MSCs and MSCs-Exo, highlighting their broad applicability in DN treatment. This review aims to provide a comprehensive summary of the scientific developments in treating DN using MSCs and MSCs-Exo from diverse sources, while also exploring their future therapeutic possibilities in detail.
引用
收藏
页数：17
相关论文
共 108 条
[1]   Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment [J].
Aghayan, Hamid Reza ;
Salimian, Fatemeh ;
Abedini, Atefeh ;
Ghazi, Samrand Fattah ;
Yunesian, Masud ;
Alavi-Moghadam, Sepideh ;
Makarem, Jalil ;
Majidzadeh-A, Keivan ;
Hatamkhani, Ali ;
Moghri, Maryam ;
Danesh, Abbas ;
Haddad-Marandi, Mohammad Reza ;
Sanati, Hassan ;
Abbasvandi, Fereshteh ;
Arjmand, Babak ;
Azimi, Pourya ;
Ghavamzadeh, Ardeshir ;
Sarrami-Forooshani, Ramin .
STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
[2]   Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model [J].
An, Xingxing ;
Liao, Guangneng ;
Chen, Younan ;
Luo, Ai ;
Liu, Jingping ;
Yuan, Yujia ;
Li, Lan ;
Yang, Lichuan ;
Wang, Hong ;
Liu, Fang ;
Yang, Guang ;
Yi, Shounan ;
Li, Yuanmin ;
Cheng, Jingqiu ;
Lu, Yanrong .
STEM CELL RESEARCH & THERAPY, 2019, 10 (01)
[3]   CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease [J].
Anders, Hans-Joachim ;
Huber, Tobias B. ;
Isermann, Berend ;
Schiffer, Mario .
NATURE REVIEWS NEPHROLOGY, 2018, 14 (06) :361-377
[4]   Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes [J].
Arabpour, Maedeh ;
Saghazadeh, Amene ;
Rezaei, Nima .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97
[5]   Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines [J].
Bai, Yihua ;
Wang, Jiaping ;
He, Zhenkun ;
Yang, Min ;
Li, Luohua ;
Jiang, Hongying .
MEDICAL SCIENCE MONITOR, 2019, 25 :3069-3076
[6]   The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review [J].
Bian, Donghui ;
Wu, Yan ;
Song, Guodong ;
Azizi, Ramyar ;
Zamani, Amir .
STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
[7]   Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells [J].
Bian, Xiaohui ;
Conley, Sabena M. ;
Eirin, Alfonso ;
Zuckerman, Eric Zimmerman A. ;
Smith, Anastasia L. ;
Gowan, Cody C. ;
Snow, Zachary K. ;
Jarmi, Tambi ;
Farres, Houssam ;
Erben, Young M. ;
Hakaim, Albert G. ;
Dietz, Matthew A. ;
Zubair, Abba C. ;
Wyles, Saranya P. ;
Wolfram, Joy V. ;
Lerman, Lilach O. ;
Hickson, LaTonya J. .
STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
[8]   Chitosan Hydrogel Supplemented with Metformin Promotes Neuron-like Cell Differentiation of Gingival Mesenchymal Stem Cells [J].
Cai, Shanglin ;
Lei, Tong ;
Bi, Wangyu ;
Sun, Shutao ;
Deng, Shiwen ;
Zhang, Xiaoshuang ;
Yang, Yanjie ;
Xiao, Zhuangzhuang ;
Du, Hongwu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
[9]   Exosomes from mesenchymal stem cells expressing microribonucleic acid-125b inhibit the progression of diabetic nephropathy via the tumour necrosis factor receptor-associated factor 6/Akt axis [J].
Cai, Xia ;
Zou, Fang ;
Xuan, Rui ;
Lai, Xiao-Yang .
ENDOCRINE JOURNAL, 2021, 68 (07) :817-828
[10]   Cellular senescence: when bad things happen to good cells [J].
Campisi, Judith ;
di Fagagna, Fabrizio d'Adda .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) :729-740
12345678910